Search
for
Sort by
Research 601–630 of 1000+
- Associated comorbidities in pediatric patients with alopecia areata
- Dental Rehabilitation of a Child Diagnosed With Alopecia Areata Totalis: A Case Report
- Individualistic homoeopathic management of alopecia barbae based on characteristic mental symptom: A case report
- Exploring the association between alopecia areata and thyroid dysfunction: A review
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Clinical positioning and future prospects of JAK inhibitors in alopecia areata
- Prevalence, Risk Factors, and Management Strategies of Alopecia in Saudi Arabia: A Systematic Review
- Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Associated comorbidities in pediatric patients with alopecia areata
- Complete Reversal of Alopecia Universalis Using Tofacitinib in a Patient with Rheumatoid Arthritis: A Case Report
- Stem cell-based therapies for alopecia areata: a narrative review
- Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
- Genotype-Phenotype Delineation of Autoimmune Polyendocrinopathy, Candidiasis, and Ectodermal Dystrophy in a Pediatric Patient: A Case Report
- Pharmacotherapy of alopecia areata
- Autoimmune skin disease pathogenesis: a chronological immune cascade and multi-hit model
- Clinical Outcome of Ayurvedic Management of Indralupta (Alopecia Areata)- A Case Study
- Alopecia Areata (Indralupt) an Ayurvedic approach – a case study
- THERAPEUTIC EFFICACY OF RAKTAMOKSHANA AND SHAMANA CHIKITSA IN THE AYURVEDIC MANAGEMENT OF INDRALUPTA (ALOPECIA AREATA): A CASE REPORT
- Merciful Malady: Renbök Phenomenon Between Alopecia Areata and Psoriasis Vulgaris
- Exploration of Potential Secondary Plant Metabolites for the Treatment of Alopecia Areata
- Therapeutic Approaches for Alopecia Areata in Children Aged 6 to 11 Years
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Table 1_Association between SQSTM1 dysregulation and risk in alopecia areata: a Mendelian randomization study.docx
- 042 Characterization of Pathogenic CD8+ T Cells in an adoptive transfer Mouse Model of Alopecia Areata in C3H/HeJ mice
- Environmental Modulation of JAK3-Mediated Immune Dysregulation in Alopecia Areata
- Effect of Systemic Immunomodulators on Incidence of Alopecia Areata: A Retrospective Cohort Study
- Skin γδ T cell subsets have distinct functions in alopecia areata 3844
- A humanized IL-2 fusion protein enhances T regulatory cells in vivo and restrains disease in a murine model of Alopecia Areata 4760
- T <sub>H</sub> 1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Characterization of thyroid disorders in alopecia areata patients: A cross-sectional evaluation